BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 22125205)

  • 1. [Endogenous cardioprotective mechanisms - what is it about and how does it work?].
    Beręsewicz A
    Kardiol Pol; 2011; 69 Suppl 3():59-66. PubMed ID: 22125205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The endogenous cardioprotection during reperfusion in acute myocardial infarction].
    Zalewski J; Nessler J
    Kardiol Pol; 2011; 69 Suppl 3():67-74. PubMed ID: 22125206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial permeability transition pore and postconditioning.
    Gateau-Roesch O; Argaud L; Ovize M
    Cardiovasc Res; 2006 May; 70(2):264-73. PubMed ID: 16581044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
    Heusch G
    Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning.
    Hausenloy DJ; Tsang A; Yellon DM
    Trends Cardiovasc Med; 2005 Feb; 15(2):69-75. PubMed ID: 15885573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed postconditioning in the mouse heart in vivo.
    Roubille F; Franck-Miclo A; Covinhes A; Lafont C; Cransac F; Combes S; Vincent A; Fontanaud P; Sportouch-Dukhan C; Redt-Clouet C; Nargeot J; Piot C; Barrère-Lemaire S
    Circulation; 2011 Sep; 124(12):1330-6. PubMed ID: 21875909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Realizing the clinical potential of ischemic preconditioning and postconditioning.
    Yellon DM; Hausenloy DJ
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria "THE" target of myocardial conditioning.
    Boengler K; Lochnit G; Schulz R
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1215-H1231. PubMed ID: 30004243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postconditioning: from the bench to bedside.
    Cour M; Gomez L; Mewton N; Ovize M; Argaud L
    J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):117-30. PubMed ID: 20938041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent inhibition of mitochondrial permeability transition by preconditioning during the first hours of reperfusion.
    Argaud L; Loufouat J; Gateau-Roesch O; Gomez L; Robert D; Ovize M
    Shock; 2008 Nov; 30(5):552-6. PubMed ID: 18317409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postconditioning inhibits mitochondrial permeability transition.
    Argaud L; Gateau-Roesch O; Raisky O; Loufouat J; Robert D; Ovize M
    Circulation; 2005 Jan; 111(2):194-7. PubMed ID: 15642769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can any heart be preconditioned? Influence of aging and comorbidities on cardioprotection].
    Bilińska M
    Kardiol Pol; 2011; 69 Suppl 3():85-8. PubMed ID: 22125209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mitochondria permeability transition as a target for ischemic preconditioning].
    Hoshovs'ka IuV; Shymans'ka TV; Rudyk OV; Korkach IuP; Sahach VF
    Fiziol Zh (1994); 2011; 57(4):34-45. PubMed ID: 22164407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efforts to reduce myocardial infarct size--the next step.
    Braunwald E
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):349-53. PubMed ID: 21821538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnesium orotate elicits acute cardioprotection at reperfusion in isolated and in vivo rat hearts.
    Mirica SN; Duicu OM; Trancota SL; Fira-Mladinescu O; Angoulvant D; Muntean DM
    Can J Physiol Pharmacol; 2013 Feb; 91(2):108-15. PubMed ID: 23458194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preconditioning tachycardia decreases the activity of the mitochondrial permeability transition pore in the dog heart.
    Sánchez G; Fernández C; Montecinos L; Domenech RJ; Donoso P
    Biochem Biophys Res Commun; 2011 Jul; 410(4):916-21. PubMed ID: 21708132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emulsified isoflurane protects rat heart in situ after regional ischemia and reperfusion.
    Hu ZY; Peng XY; Liu F; Liu J
    Fundam Clin Pharmacol; 2014 Apr; 28(2):190-8. PubMed ID: 23600699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning.
    Hausenloy DJ; Ong SB; Yellon DM
    Basic Res Cardiol; 2009 Mar; 104(2):189-202. PubMed ID: 19242644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant early and late cardioprotective therapy: access to the heart.
    Hinkel R; Boekstegers P; Kupatt C
    Cardiovasc Res; 2012 May; 94(2):226-36. PubMed ID: 22318936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.